Published in Arch Intern Med on February 23, 1981
The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers | NCT00594867
Late mortality in elderly patients surviving acute peptic ulcer bleeding. Gut (1995) 1.00
Paracetamol and phenacetin. Drugs (1986) 0.99
Non-steroidal anti-inflammatory agents and the gastrointestinal tract. Postgrad Med J (1986) 0.99
Aspirin and related derivatives of salicylic acid. Drugs (1986) 0.77
Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects. Can Fam Physician (1991) 0.75
Gastrointestinal intolerance and bleeding with non-narcotic analgesics. Drugs (1986) 0.75
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Antidepressants and suicide. BMJ (1995) 4.84
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Comprehensive drug surveillance. JAMA (1970) 2.92
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 2.00
Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol (1997) 1.99
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88
Antidepressant drugs and suicide. J Clin Psychopharmacol (1992) 1.80
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med (1994) 1.79
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis (2000) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception (1999) 1.62
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet (1998) 1.61
Evaluation of drug efficacy by a preference technic. N Engl J Med (1966) 1.60
Haemophilus influenzae vaccine. Br J Gen Pract (1995) 1.59
A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy (1997) 1.55
Vasectomy and non-fatal myocardial infarction. Lancet (1981) 1.54
Drug-related deaths among medical inpatients. JAMA (1977) 1.53
First trimester topical tretinoin and congenital disorders. Lancet (1993) 1.45
Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1978) 1.45
Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA (1986) 1.45
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med (2000) 1.44
Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol (1984) 1.38
Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy (2000) 1.38
Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med (1986) 1.38
Temporal and regional variation in hysterectomy rates in the United States, 1970--1975. Am J Epidemiol (1979) 1.37
Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (1998) 1.36
Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis (1982) 1.35
Cholestatic hepatitis associated with flucloxacillin. Med J Aust (1993) 1.34
First-trimester drug use and congenital disorders. JAMA (1981) 1.34
Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms. Lancet (1977) 1.33
Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis (1981) 1.33
Oral contraceptives and breast cancer. Am J Epidemiol (1980) 1.32
Assessment of adverse reactions within a drug surveillance program. JAMA (1968) 1.23
Cancer of the corpus uteri: increasing incidence in the United States, 1970--1975. Am J Epidemiol (1979) 1.22
Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agent. Am Heart J (1969) 1.21
Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA (1976) 1.20
Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet (1999) 1.20
Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol (2001) 1.19
Computer analysis of epidemiologic data on effect of drugs on hospital patients. Public Health Rep (1969) 1.19
Third-generation oral contraceptives and venous thrombosis. Lancet (1997) 1.16
Adverse reactions to co-trimoxazole in hospitalized medical patients. Am J Med Sci (1978) 1.15
Atracurium--a post-marketing surveillance study: U.K. study and discussion. Br J Anaesth (1989) 1.15
Appendectomy protects against ulcerative colitis. Epidemiology (1998) 1.15
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol (2000) 1.14
Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet (1987) 1.14
Myocardial infarction and estrogen therapy in post-menopausal women. N Engl J Med (1976) 1.13
Oral contraceptives and nonfatal vascular disease. Obstet Gynecol (1985) 1.13
The turnover of microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in the livers of mice treated with phenobarbital. J Biol Chem (1966) 1.13
Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ (1994) 1.13
Vaginal spermicides and gonorrhea. JAMA (1982) 1.12
Statin use, hyperlipidaemia, and the risk of breast cancer. Br J Cancer (2002) 1.10
Diphtheria-tetanus-pertussis immunization and sudden infant death syndrome. Am J Public Health (1987) 1.09
The epidemiology o digoxin. A study in three Boston hospitals. J Chronic Dis (1969) 1.09
Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ (1998) 1.09
Pyloric stenosis and maternal Bendectin exposure. Am J Epidemiol (1984) 1.07
Replacement estrogens and breast cancer. Am J Epidemiol (1980) 1.06
Declining rates of endometrial cancer. Obstet Gynecol (1980) 1.04
Drug-induced blood disorders. JAMA (1984) 1.03
Life threatening drug reactions amongst medical in-patients. Scott Med J (1979) 1.03
Nonestrogenic drugs and breast cancer. Am J Epidemiol (1982) 1.03
Drug prescribing in hospitals: an international comparison. Am J Public Health (1976) 1.03
Drug monitoring of surgical patients. JAMA (1982) 1.03
Postmarketing follow-up. JAMA (1979) 1.02
Myocardial infarction and other vascular diseases in young women. Role of estrogens and other factors. JAMA (1978) 1.02
Neurologic events following diphtheria-tetanus-pertussis immunization. Pediatrics (1988) 1.01
Potentiation of ampicillin skin reactions by allopurinol or hyperuricemia. J Clin Pharmacol (1981) 1.01
Maternal heat exposure and neural tube defects. JAMA (1992) 1.00
Liver disorders in patients receiving chlorpromazine or isoniazid. Pharmacotherapy (1993) 1.00
Oral-contraceptive-induced benign liver tumors--the magnitude of the problem. JAMA (1978) 1.00
First-trimester drug use and congenital disorders. Obstet Gynecol (1985) 1.00
Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiology (2001) 0.99
Nonsteroidal anti-inflammatory drugs and renal disease. JAMA (1984) 0.99